Journal of Neuroinflammation · 2021 · 30 citations · 19 references
MedicineClinical SciencesNeurologyCerebrovascular SurgeryClinical NeuroscienceMolecular PathologyAcute Ischemic StrokeCerebrovascular DiseaseNeurovascular DysfunctionStrokeStroke SurgeryThrombosisBiomarker-based PrognosticationBiomarkersIntracranial Large Vessel OcclusionIschemic Stroke PrognosticationNeurofilament ProteinsPlasma Protein BiomarkersPrognostic PredictionStroke Biomarkers
Abstract Background Timely endovascular thrombectomy (EVT) significantly improves outcomes in patients with acute ischemic stroke (AIS) with large vessel occlusion type. However, whether certain central nervous system-specific plasma biomarkers correlate with the outcomes is unknown. We evaluated the temporal changes and prognostic roles of the levels of these biomarkers in patients with AIS undergoing EVT. Methods We enrolled 60 patients who received EVT for AIS and 14 controls. The levels of plasma biomarkers, namely neurofilament light chain (NfL), glial fibrillary astrocytic protein (GFAP), tau, and ubiquitin C-terminal hydrolase L1 (UCHL1), were measured with an ultrasensitive single molecule array before, immediately after, and 24 h after EVT (T1, T2, and T3, respectively). The outcomes of interest were death or disability at 90 days (defined as a modified Rankin Scale score of 3–6) and types of hemorrhagic transformation (hemorrhagic infarction or parenchymal hemorrhage). Results Of the 180 blood samples from the 60 patients who received EVT, the plasma NfL, GFAP, and UCHL1 levels at T1 were significantly higher than those of the controls, and the levels of all four biomarkers were significantly higher at T3. Patients with parenchymal hemorrhage had a significantly higher rate of increase in GFAP ( P interaction = 0.005) and UCHL1 ( P interaction = 0.007) levels compared with those without parenchymal hemorrhage. In a multivariable analysis with adjustment for age, sex, National Institute of Health Stroke Scale score, history of atrial fibrillation, and recanalization status, higher NfL levels at T1 (odds ratio [OR] 2.05; 95% confidence interval [CI], 1.03–4.08), T2 (OR, 2.08; 95% CI, 1.05–4.01), and T3 (OR, 3.94; 95% CI, 1.44–10.79) were independent predictors of death or disability at 90 days. Conclusion Among patients with AIS who received EVT, those with hemorrhagic transformation exhibited significant increase in plasma GFAP and UCHL1 levels over time. Higher plasma NfL were predictive of unfavorable functional outcomes.
19
Harold P. Adams, Birgitte H. Bendixen, L. Jaap Kappelle et al. · Stroke · 1993 · 12.3K citations · Full text
Glutamate neurotoxicity and diseases of the nervous system
Dennis W. Choi · Neuron · 1988 · 8K citations
Isolated Hand Paresis: A Case Series
Karl Bjørnar Alstadhaug, Ane Skaare Sjulstad · Cerebrovascular Diseases Extra · 2013 · 4.1K citations · Full text
Medicine, Anatomy, Neuroscience +15
Significance of Large Vessel Intracranial Occlusion Causing Acute Ischemic Stroke and TIA
Wade S. Smith, Michael H. Lev, Joey English et al. · Stroke · 2009 · 500 citations